All In MedTech

Device Trial Radar · NCT05311124

Direct Application of Integra Bilayer Matrices on Bare Calvarium Without Preliminary Burring

Direct Application of Integra Bilayer Matrices on Bare Calvarium Without Preliminary Burring: A Clinical and Histologic Study of Efficacy

Last checked: Nov 19, 2026Latest source record: Oct 18, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

10

Planned (sponsor's estimate)

Start

Aug 1, 2022

Primary completion

Jun 1, 2023

Study completion Oct 1, 2023

Sponsor

Lead sponsor
Joshua ChooAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Integra LifeSciences Corporation
First posted
Apr 5, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 55 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is to determine if large, full thickness scalp wounds with exposed calvarium resulting from acutely created extirpative defects can be reliably and durably resurfaced with IDRT without burring or fenestration as a preliminary step, regardless of the size of the calvarial defect.

Conditions

  • Wound Care
  • Pressure Ulcer
  • Venous Ulcer
  • Surgical Wound
  • Trauma Wounds
  • Draining Wound

Interventions

  • Integra Dermal Regeneration template (IDRT)Device

    Integra Dermal Regeneration Template is a two-layer skin regeneration system. The outer layer is made of a thin silicone film that acts as your skin's epidermis. It protects the wound from infection and controls both heat and moisture loss. The inner layer is constructed of a complex matrix of cross-linked fibers. This porous material acts as a scaffold for regenerating dermal skin cells, which enables the re-growth of a functional dermal layer of skin. Once dermal skin has regenerated, the silicone outer layer is removed and replaced with a thin epidermal skin graft.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to complete closureTime frame: 10 - 12 months for study
  2. Percentage of subjects with complete closure of defectTime frame: 10 - 12 months for study

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Louisville School of Medicine Division of Plastic Surgery

    Louisville, Kentucky · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.